Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Sep 1986 |
硫酸镁无菌溶液在伤口缝合术后患者中局部多次给药的药代动力学与安全性试验研究
[Translation] A pharmacokinetics and safety study of sterile magnesium sulfate solution in patients after wound suture surgery after multiple topical administration
主要目的:通过在伤口缝合术后患者中多次局部外用由石家庄杏泽医药科技有限公司提供的硫酸镁无菌溶液,评价本品局部多次给药后的药代动力学特征和全身吸收蓄积情况。
次要目的:观察硫酸镁无菌溶液局部多次给药的安全性/耐受性。
[Translation] Primary objective: To evaluate the pharmacokinetic characteristics and systemic absorption accumulation of this product after multiple topical administration of sterile magnesium sulfate solution provided by Shijiazhuang Xingze Pharmaceutical Technology Co., Ltd. in patients after wound suture surgery.
Secondary objective: To observe the safety/tolerability of multiple topical administration of sterile magnesium sulfate solution.
100 Clinical Results associated with Shijiazhuang Penghai Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shijiazhuang Penghai Pharmaceutical Co., Ltd.
100 Deals associated with Shijiazhuang Penghai Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shijiazhuang Penghai Pharmaceutical Co., Ltd.